NewsRoom Articles - Page 175 of 613

TuesdayAug 30, 2022 4:20 pm

420 with CNW — How Missouri Activists Overcame Setbacks to Put Cannabis Measure on Upcoming Ballot

Cannabis reform activists in Missouri have managed to get their legalization bill on the November ballot after being bogged down by setbacks and nearly forced to give up on their bill. According to unofficial tallies, the Legal Missouri campaign had not collected enough signatures to qualify for the upcoming ballot by late July, being 2,275 signatures short. With the ballot fast approaching, many feared the campaign's hope of gathering enough signatures in time would be dashed. But activists behind the campaign managed to pull a major comeback, collecting the remaining 2,275 signatures by Aug. 9, 2022, and qualifying the legalization…

TuesdayAug 30, 2022 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces the Availability of a Broadcast titled, “The Power of Science to Stop a Killer”

Lexaria’s latest broadcast highlights the company’s progress in finding a potential solution for hypertension treatment while also pointing out why such a solution is much needed at this point Since the company began developing its patented DehydraTECH(TM) technology in 2014, it has made significant progress in its clinical studies, even as it currently focuses on human clinical research to evaluate the tolerability, safety, and efficacy of its solution for hypertension treatment Lexaria expressed its confidence in its proposed solution, noting that it will not only be a safer but also better-tolerated drug candidate, unlike current alternatives in the market whose…

TuesdayAug 30, 2022 4:20 am

420 with CNW — Recent Studies Show Advanced Cancer Sufferers Could Benefit from Using Marijuana

Over the past couple of years, a surge in cannabis research has revealed that the controversial plant has a variety of medical applications. Despite being classified as a Schedule I drug with no medical application, studies have found that cannabis can be effective at alleviating conditions such as chronic pain, depression and insomnia. Furthermore, the U.S. Food and Drug Administration has also approved a CBD-based drug called Epidiolex to treat seizures in pediatric epilepsy. In recent months, research into the impact of cannabis on cancer treatment has found that the plant can have a positive impact on cancer patients. Cancer…

MondayAug 29, 2022 4:20 pm

420 with CNW — Marijuana Firms in Virginia Expand Facilities Despite Uncertainty Over Recreational Sales

Last year, legislators in Virginia approved a measure to legalize its commercial recreational cannabis market and launch it in 2024, which would make it the first of its kind in the South. At the time, Democrats were in control of the state’s government. However, once Republicans reclaimed the governor’s mansion and the House of Delegates in November, whether the state’s adult-use program would actually be launched at the stipulated time was thrown into disarray. Despite this, marijuana multistate operators remain focused on expanding their medical cannabis facilities. For instance, representatives from Columbia Care and Jushi Holdings have revealed that their…

MondayAug 29, 2022 9:00 am

AROYA Crop Steering Expertise and Technology Provides Data-Driven Insights, Automation and Competitive Advantage for Successful Harvests

For cannabis operators, crop steering directs how their plants grow as well as their literal shape. Knowing how and when to manipulate light, climate and irrigation – the three foundational components of crop steering – is essential to balancing high yields and high quality. Why do successful growers – from small craft farmers to the largest multistate operators – use data-driven and automated crop steering solutions? Because even the slightest adjustments to any number of factors can have huge effects on grows. Data is the lifeblood of a plant growers, providing the intelligence to track how and when plants change…

MondayAug 29, 2022 4:20 am

420 with CNW — Experts Say Federal Court Ruling in Maine Could Pave Way for Interstate Cannabis Commerce

Last week, a federal appellate court ruled that the law prohibiting nonresidents in Maine from owning medical cannabis businesses in the state violated the United States’ constitution. Stakeholders in the industry have been monitoring the case keenly, with many arguing that the dormant commerce clause of the constitution applies to the cannabis industry, despite ongoing federal marijuana prohibition. Legal experts believe that this ruling may have extensive implications for interstate marijuana commerce, with some noting that it could create potential complications for social equity programs. In the 2 to 1 ruling, the U.S. Court of Appeals for the First Circuit…

FridayAug 26, 2022 4:20 pm

420 with CNW — DOT Tables New Guidelines on CBD on the Certification of Commercial Drivers

The cannabidiol (CBD) revolution has been fantastic to behold. In just a few short years, the cannabis extract went from virtual anonymity to being one of the most searched-for items on the web. CBD is said to have a plethora of medical applications, including alleviating anxiety, chronic pain and insomnia, and it has been subject to significant consumer and scientific interest in recent years. However, cannabidiol use is still frowned upon by plenty of employers, including the federal government. This is despite the fact that unlike delta-9 THC, the main psychoactive agent in cannabis, CBD does not intoxicate users. In…

FridayAug 26, 2022 11:15 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Drug Development Program and Recent FDA Confirmation Position It for Favorable Valuation

Lexaria is a global innovator of drug delivery platforms, including its patented DehydraTECH(TM) technology The company recently released information that would help its stakeholders research and understand how biotech and pharmaceutical companies are valued Based on some of the methodologies used in valuation, Lexaria is positioned favorably as its DehydraTECH-processed CBD for the treatment of hypertension has successfully reached the IND application stage, with the program recently receiving an additional boost The FDA agreed with Lexaria’s proposal to pursue a 505(b)(2) new drug application (“NDA”) regulatory pathway, an abbreviated pathway, for its hypertension program As a follow-up to recent coverage…

FridayAug 26, 2022 4:20 am

420 with CNW — Mothers in Indonesia Fight for Their Children to Have Access to Medical Cannabis

Medical cannabis has been found to be a viable treatment for a wide variety of medical conditions in recent years. Studies have revealed that the plant can be effective against health issues such as chronic pain, anxiety, insomnia and depression. Furthermore, the US Food and Drug Administration has approved the use of a CBD-based drug called Epidiolex to treat seizures in pediatric epilepsy. In Indonesia, a group of mothers is fighting to get their children access to cannabis, a plant they say could alleviate the pain caused by illnesses such as cerebral palsy. Pika Sasi Kirana was diagnosed with cerebral…

ThursdayAug 25, 2022 4:20 pm

420 with CNW — Uncertainty Grows Over When Germany Will Legalize Marijuana

Germany has spent the past couple of months mulling over whether or not it should legalize cannabis, a move that would potentially turn the country into the world’s largest market for legal cannabis. With Germany’s left-liberal government pushing on with plans to legalize adult-use cannabis in the country, the coalition government has undertaken a series of public hearings with cannabis growers, economists and health experts to help inform the legalization process. If Germany chooses to legalize recreational cannabis, the move could put pressure on its neighbors to follow its lead and create enough momentum to change the UN convention barring…

News and publishing service for cannabis related companies

Contact us: 512.354.7000